Optimizing Pharmacological Management in Pediatric Obesity
Received Date: Mar 02, 2024 / Published Date: Mar 30, 2024
Abstract
uch as type 2 diabetes, cardiovascular disease, and psychosocial issues. Pharmacological management has emerged as a complementary strategy to lifestyle modifications in addressing this complex condition. This discussion explores the current landscape of pharmacological treatments for pediatric obesity, focusing on optimizing their use to enhance efficacy and safety. Key pharmacological agents, including orlistat, metformin, and GLP-1 receptor agonists, have demonstrated varying degrees of effectiveness in promoting weight loss and improving metabolic outcomes in children and adolescents. While these medications offer potential benefits, their success is contingent upon careful patient selection, appropriate dosing, and comprehensive monitoring to mitigate side effects and ensure long-term safety
Citation: Mahbod S (2024) Optimizing Pharmacological Management in PediatricObesity. Neonat Pediatr Med 10: 400.
Copyright: © 2024 Mahbod S. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Conferences
Vancouver, Canada
Toronto, Canada
Toronto, Canada
Recommended Journals
黑料网 Journals
Article Usage
- Total views: 150
- [From(publication date): 0-2024 - Nov 22, 2024]
- Breakdown by view type
- HTML page views: 121
- PDF downloads: 29
